Skip to content

A randomized and controlled study of moxibustion Zi Gong acupoint and Guan Yuan acupoint in the treatment of perimenopausal syndrome

A randomized and controlled study of moxibustion Zi Gong acupoint and Guan Yuan acupoint in the treatment of perimenopausal syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000393
Enrollment
Unknown
Registered
2024-09-06
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perimenopausal syndrome

Interventions

Kuntai capsule group:Oral Kuntai capsules
moxibustion group:moxibustion on guanyuan acupoint and zigong acupoint

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Gender: female 45 years old= age = 55 years old 2. Symptoms: menstrual changes hot flashes and sweating irritability depression palpitations insomnia vaginal dryness osteoporosis and other symptoms. Laboratory tests: decreased estradiol (E2) (40 UI/L) 3. Voluntarily participate in this survey and have good compliance and sign the patient's informed consent form.

Exclusion criteria

Exclusion criteria: 1. Have other medical conditions that affect estrogen levels. 2. Those who have received endocrine therapy in the past 1 month or have taken drugs or health foods for the treatment of menopausal syndrome. 3. Patients with unexplained vaginal bleeding or who are using anticoagulant drugs or have abnormal coagulation function. 4. Those with serious comorbidities. 5. Patients who have participated in other clinical trials that have an impact on this study in the past 2 months. 6. Those who have infection or scar on the local skin of the acupuncture points and cannot be treated with moxibustion.

Design outcomes

Primary

MeasureTime frame
kupperman scale score;

Secondary

MeasureTime frame
LH;AMH;Self-rated depression scale score;Pittsburgh Sleep Quality Scale score;FSH;E2;Perimenopausal Quality of Life Scale;Self-rated anxiety scale score;

Countries

China

Contacts

Public ContactQingchen Zhou

Qilu Hospital of Shandong University

zzcybyq@163.com18560089830

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026